The report evaluates 35 providers delivering digital services to life sciences enterprises, including biopharmaceutical and medical device companies, based on their ability to enable transformation through scalable, co-innovative solutions and differentiated digital capabilities.
As life sciences organizations face increased complexity and economic pressures, digital services have become essential to improve operational resilience and accelerate time-to-market.
The report recognizes providers making targeted investments in areas such as AI and generative AI, data platforms, and industry-specific solutions to support transformation across the life sciences value chain.
"We are proud to be recognized by Everest Group as a Major Contender in the Life Sciences Digital Services PEAK Matrix®,” said Anand Kumar, Head of Life Sciences at Virtusa.
“This acknowledgement reflects our commitment to helping life sciences clients digitize the value chain - from clinical development to commercial operations - using data-driven platforms, automation, and AI.
Our focus remains on building scalable digital solutions that bring faster innovation and better health outcomes to market."
Virtusa partners with global life sciences companies to tackle complex industry challenges, including decentralized trials, pharmacovigilance modernization, and AI-enabled supply chain optimization.
The company has delivered measurable impact for biopharma and medtech clients.
The 2025 PEAK Matrix® assessment provides an in-depth analysis of market adoption, innovation, delivery footprint, and capabilities of each provider.
It serves as a trusted resource for life sciences leaders evaluating strategic partners for their digital agendas.